Displaying 1–25 of 54 results for Meagan Parrish, Senior Editor
As far as M&A deals go, 2019 has started off with a boom.
Lucrative compensation packages for CEOs are certainly not unique to pharma. But many of the industry's top dogs got hefty raises last year, showing it's a good time to be a CEO in pharma.
How the pharma industry's big ideas are impacting sterile manufacturing
A wave of incoming anti-inflammatories and gene therapies that could make it big
CPhI N. America's keynote speaker explains what bipartisan bickering means for pharma
Why the industry is forming bonds with CBD
Innovations in materials and components play a critical role in protecting product quality
In pharma plants, age definitely matters.
Vendors bring new features to mixing technology
PDA’s Annual Meeting found lessons in the industry’s continued ups and downs
A leader in biotech explains what it’s like to do business in China, what challenges companies are up against and what kind of innovative solutions have been proven to work
The biggest case of fraud in biotech history is getting its day in the spotlight.
New business management solutions offer end-to-end manufacturing connections
How pharma companies fair on Glassdoor.
Can the industry fix its image problem?
The latest technologies build on past innovations to boost efficiency for manufacturers.
ADC BIO’s innovative technology is helping to usher in oncology’s new age of therapeutic agents
Berkshire Sterile Manufacturing’s souped-up isolator system offers a first-of-its-kind process for sterile manufacturing
Last year, the FDA once again set a new record for new drug approvals and far surpassed its 10-year average.
In the coming year, several drugs that treat a range of diseases will far surpass the $1 billion blockbuster mark and continue to grow.
A mix of the biggest hits from 2018
As Pharmaceutical Manufacturing sends its final issue of 2018 to the printer, we’d like to take this opportunity to reflect on some of our favorite highlights:
From minor updates to high-tech changes, vendors are helping pharma meet strict cleanroom standards
Top five sights from our Netherlands biopharma industry tour